The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide

Abstract

Our findings suggest Abeta is a hitherto unrecognized AMP that may normally function in the innate immune system. This finding stands in stark contrast to current models of Abeta-mediated pathology and has important implications for ongoing and future AD treatment strategies.